Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

15.24 -1.76 (-10.35%)

Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Mineralys Therapeutics, Inc. - Common Stock

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

September 20, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

September 12, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

September 09, 2024

From Schall Law

Via GlobeNewswire

Praxis Bioresearch Expands its Board of Directors with Appointment of Adam Levy

September 19, 2023

From Praxis Bioresearch, Inc.

Via GlobeNewswire

There's a Lot to Love About Mineralys' Valentine's Day IPO

February 13, 2023

MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million

Via MarketBeat

Topics Initial Public Offering

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.